🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Њујорк › Rochester

Kliničke studije za Akutna mijeloidna leukemija u gradu Rochester, NY

18 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Rochester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome

Тражи се учесникОпсервациона студија
  • University of Rochester Medical Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT01311258

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст 60 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07437950

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 3
  • University of Rochester Medical Center, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • Rochester General Hospital, Rochester
  • University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Тражи се учесникФаза 3
  • University of Rochester Medical Center (URMC), Rochester
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Тражи се учесникОпсервациона студија
  • University of Rochester, Rochester
Узраст 0 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT07154823

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • University of Rochester, Rochester
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

A Telehealth Advance Care Planning Intervention

Тражи се учесник
  • University of Rochester, Rochester
Узраст 60 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT05875805

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • Wilmot Cancer Institute, University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Тражи се учесник
  • University of Rochester Medical Center, Rochester
Узраст 60 и старији · Оба пола · Ажурирано 6. 7. 2026. · NCT06697600

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • Strong Memorial Hospital/University of Rochester, Rochester
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Тражи се учесникРана фаза 1
  • Wilmot Cancer Institute, University of Rochester, Rochester
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 6. 2026. · NCT03964506

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Тражи се учесникФаза 1/2
  • The University of Rochester, Rochester
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT05732103

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Тражи се учесникЗдраве особе су добродошле
  • University of Rochester, Rochester
Узраст од 18 до 120 · Оба пола · Ажурирано 25. 7. 2025. · NCT05237258

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Rochester

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.